These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 11683345
1. Correlation between the levels of circulating adhesion molecules and PR3-ANCA in Wegener's granulomatosis. Takizawa M, Maguchi S, Nakamaru Y, Miyatake Y, Fukuda S, Inuyama Y. Auris Nasus Larynx; 2001 May; 28 Suppl():S59-62. PubMed ID: 11683345 [Abstract] [Full Text] [Related]
2. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis. Csernok E, Ahlquist D, Ullrich S, Gross WL. Rheumatology (Oxford); 2002 Nov; 41(11):1313-7. PubMed ID: 12422006 [Abstract] [Full Text] [Related]
3. Leucocyte membrane expression of proteinase 3 correlates with disease activity in patients with Wegener's granulomatosis. Muller Kobold AC, Kallenberg CG, Tervaert JW. Br J Rheumatol; 1998 Aug; 37(8):901-7. PubMed ID: 9734683 [Abstract] [Full Text] [Related]
4. Measurements of proteinase 3 and its complexes with alpha 1-proteinase inhibitor and anti-neutrophil cytoplasm antibodies (ANCA) in plasma. Baslund B, Petersen J, Permin H, Wiik A, Wieslander J. J Immunol Methods; 1994 Oct 14; 175(2):215-25. PubMed ID: 7930650 [Abstract] [Full Text] [Related]
11. Relevance of classic anti-neutrophil cytoplasmic autoantibody (C-ANCA)-mediated inhibition of proteinase 3-alpha 1-antitrypsin complexation to disease activity in Wegener's granulomatosis. Dolman KM, Stegeman CA, van de Wiel BA, Hack CE, von dem Borne AE, Kallenberg CG, Goldschmeding R. Clin Exp Immunol; 1993 Sep 14; 93(3):405-10. PubMed ID: 8370167 [Abstract] [Full Text] [Related]
13. Interference of Wegener's granulomatosis autoantibodies with neutrophil Proteinase 3 activity. van de Wiel BA, Dolman KM, van der Meer-Gerritsen CH, Hack CE, von dem Borne AE, Goldschmeding R. Clin Exp Immunol; 1992 Dec 14; 90(3):409-14. PubMed ID: 1458677 [Abstract] [Full Text] [Related]
14. T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG). Brouwer E, Stegeman CA, Huitema MG, Limburg PC, Kallenberg CG. Clin Exp Immunol; 1994 Dec 14; 98(3):448-53. PubMed ID: 7994909 [Abstract] [Full Text] [Related]
15. Elevations of neutrophil proteinase 3 in serum of patients with Wegener's granulomatosis and polyarteritis nodosa. Henshaw TJ, Malone CC, Gabay JE, Williams RC. Arthritis Rheum; 1994 Jan 14; 37(1):104-12. PubMed ID: 7907475 [Abstract] [Full Text] [Related]
17. Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis. Russell KA, Fass DN, Specks U. Arthritis Rheum; 2001 Feb 14; 44(2):463-8. PubMed ID: 11229478 [Abstract] [Full Text] [Related]
19. Image analysis: a novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener's granulomatosis. Boomsma MM, Damoiseaux JG, Stegeman CA, Kallenberg CG, Patnaik M, Peter JB, Tervaert JW. J Immunol Methods; 2003 Mar 01; 274(1-2):27-35. PubMed ID: 12609530 [Abstract] [Full Text] [Related]
20. Glycosylation of proteinase 3 (PR3) is not required for its reactivity with antineutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis. Finkielman JD, Merkel PA, Schroeder D, Hoffman GS, Spiera R, St Clair EW, Davis JC, McCune WJ, Lears A, Ytterberg SR, Hummel AM, Viss MA, Peikert T, Stone JH, Specks U, WGET Research Group. Clin Exp Rheumatol; 2009 Mar 01; 27(1 Suppl 52):S45-52. PubMed ID: 19646346 [Abstract] [Full Text] [Related] Page: [Next] [New Search]